Please login to the form below

Not currently logged in
Email:
Password:

bitopertin

This page shows the latest bitopertin news and features for those working in and with pharma, biotech and healthcare.

Abilify Maintena launches in Europe

Abilify Maintena launches in Europe

Prospects for drugs that tackle the latter remain up in the air, however; Roche's bitopertin was leading the field but generated poor results in two phase III trials reported earlier

Latest news

  • Setback for Roche as schizophrenia candidate fails studies Setback for Roche as schizophrenia candidate fails studies

    Like bitopertin both of these were being tested as add-on drugs to tackle negative symptoms, but had different mechanisms of action. ... Analysts have suggested in the past that bitopertin could achieve sales of $3bn or more if it proves effective in

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....